Related by context. Frequent words. (Click for all words.) 67 Receives Orphan Drug Designation 66 Initiates Phase II 65 Therapeutic Competitors 64 Inc Therapeutic Competitors 64 Completes Patient Enrollment 64 topical anti infective 64 Files Shelf Registration Statement 63 DRRX 63 Testim R 63 Presents Positive 63 Topical Solution 63 gets USFDA nod 62 NYMX 62 NASDAQ AKRX 62 Connetics Corporation 62 Attracting Bullish Investors 62 Inhalation Aerosol 62 Application MAA 62 FACTIVE R gemifloxacin 62 Jumps Higher 61 Barrier Therapeutics Inc. 61 Rebif ® 61 ® bortezomib 61 Company Nasdaq PRGO 61 Oral Solution 61 Nasdaq CRXL 61 Kuvan R 61 Release Tablets 61 Welcomes Analyst Initiation 60 oncolytic virus therapies 60 Transcept Pharmaceuticals 60 NASDAQ SLXP 60 Enrolls First 60 CRTX 59 interferon gamma 1b 59 Xyntha 59 Inc. Nasdaq IMGN 59 R sorafenib tablets 59 ZYFLO R 59 Earnings Postmortem 59 BYETTA ® 59 NASDAQ MYL 59 NYSE MRX 59 MNTA 59 LeMaitre Vascular Inc. 59 Q2 Loss Narrows 58 ZIOP 58 Inc. Nasdaq SEPR 58 Synergy Pharmaceuticals 58 Fortical R 58 liposomal formulation 58 ZEGERID Capsules 58 FDA Clears 58 Inc. NASDAQ MRNA 58 Nasdaq OSIP 58 BioDelivery 58 commercializing therapeutic 58 Advicor 58 OsmoPrep 58 Calls Purchased 58 RELEASES ITS QUARTERLY NUMBERS 58 Moxifloxacin 58 NYSE COV 57 PTIE 57 Wound Dressing 57 Tibotec Pharmaceuticals Ltd. 57 Idera Pharmaceuticals 57 Ovation Pharmaceuticals 57 CRXL 57 Recombinant Human 57 Tracleer R 57 Inc. NASDAQ QLTI 57 JAK inhibitor 57 TELINTRA 57 submitted Marketing Authorization 57 Single Dose 57 injectable antibiotic 57 novel anti infective 57 Visicol 57 Report companiesandmarkets.com adds 57 AUXL 57 mesylate 57 Zelapar 57 Copegus R 57 Q3 Loss Narrows 57 RESTYLANE 56 NASDAQ SHPGY 56 Calcitonin 56 refractory chronic lymphocytic 56 stable nucleic acid 56 AKRX 56 Q2 Loss Widens 56 Q1 Loss Narrows 56 Questcor Pharmaceuticals Inc. 56 Q3 Loss Widens 56 DVAX 56 Hydrochloride 56 Sciele Pharma Inc. 56 leading lipid nanoparticle 56 Puts Purchased 56 MGI PHARMA INC.